Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs GUFIC BIOSCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA GUFIC BIOSCIENCE BAL PHARMA/
GUFIC BIOSCIENCE
 
P/E (TTM) x 40.8 32.6 125.3% View Chart
P/BV x 2.3 7.9 28.7% View Chart
Dividend Yield % 1.1 0.0 3,103.0%  

Financials

 BAL PHARMA   GUFIC BIOSCIENCE
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
GUFIC BIOSCIENCE
Mar-23
BAL PHARMA/
GUFIC BIOSCIENCE
5-Yr Chart
Click to enlarge
High Rs134290 46.3%   
Low Rs63177 35.8%   
Sales per share (Unadj.) Rs193.971.2 272.2%  
Earnings per share (Unadj.) Rs1.78.2 20.3%  
Cash flow per share (Unadj.) Rs7.510.5 71.2%  
Dividends per share (Unadj.) Rs1.000.10 1,000.0%  
Avg Dividend yield %1.00 2,362.8%  
Book value per share (Unadj.) Rs40.735.9 113.3%  
Shares outstanding (eoy) m15.6996.94 16.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.53.3 15.5%   
Avg P/E ratio x59.228.4 208.4%  
P/CF ratio (eoy) x13.222.2 59.5%  
Price / Book Value ratio x2.46.5 37.3%  
Dividend payout %59.91.2 4,925.4%   
Avg Mkt Cap Rs m1,54922,620 6.8%   
No. of employees `000NANA-   
Total wages/salary Rs m553867 63.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,0426,906 44.0%  
Other income Rs m926 36.6%   
Total revenues Rs m3,0526,932 44.0%   
Gross profit Rs m2531,347 18.8%  
Depreciation Rs m91223 41.0%   
Interest Rs m12382 149.8%   
Profit before tax Rs m471,067 4.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m21270 7.9%   
Profit after tax Rs m26797 3.3%  
Gross profit margin %8.319.5 42.6%  
Effective tax rate %44.825.3 177.1%   
Net profit margin %0.911.5 7.5%  
BALANCE SHEET DATA
Current assets Rs m2,2824,641 49.2%   
Current liabilities Rs m2,0932,882 72.6%   
Net working cap to sales %6.225.5 24.3%  
Current ratio x1.11.6 67.7%  
Inventory Days Days835 21.7%  
Debtors Days Days1,1281,086 103.8%  
Net fixed assets Rs m8293,961 20.9%   
Share capital Rs m15797 161.8%   
"Free" reserves Rs m4813,381 14.2%   
Net worth Rs m6383,478 18.3%   
Long term debt Rs m3051,907 16.0%   
Total assets Rs m3,1108,602 36.2%  
Interest coverage x1.414.0 9.9%   
Debt to equity ratio x0.50.5 87.3%  
Sales to assets ratio x1.00.8 121.8%   
Return on assets %4.810.2 47.0%  
Return on equity %4.122.9 17.9%  
Return on capital %18.121.3 84.8%  
Exports to sales %66.412.5 533.1%   
Imports to sales %22.439.3 57.1%   
Exports (fob) Rs m2,020860 234.8%   
Imports (cif) Rs m6832,716 25.1%   
Fx inflow Rs m2,020860 234.8%   
Fx outflow Rs m7162,716 26.4%   
Net fx Rs m1,305-1,855 -70.3%   
CASH FLOW
From Operations Rs m-18-266 6.9%  
From Investments Rs m-222-1,907 11.6%  
From Financial Activity Rs m2442,343 10.4%  
Net Cashflow Rs m4170 2.2%  

Share Holding

Indian Promoters % 47.1 72.5 64.9%  
Foreign collaborators % 4.2 0.0 -  
Indian inst/Mut Fund % 0.1 2.2 5.9%  
FIIs % 0.1 0.5 27.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 27.5 177.4%  
Shareholders   15,060 34,424 43.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs GUFIC BIOSCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs GUFIC BIOSCIENCE Share Price Performance

Period BAL PHARMA GUFIC BIOSCIENCE S&P BSE HEALTHCARE
1-Day -4.40% -0.93% 1.18%
1-Month -17.76% -8.45% -0.75%
1-Year 40.93% 56.26% 61.82%
3-Year CAGR 19.04% 39.23% 18.16%
5-Year CAGR 5.43% 29.02% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the GUFIC BIOSCIENCE share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of GUFIC BIOSCIENCE the stake stands at 72.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of GUFIC BIOSCIENCE.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

GUFIC BIOSCIENCE paid Rs 0.1, and its dividend payout ratio stood at 1.2%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of GUFIC BIOSCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.